Clinical Trial Update: SHAPE Neoadjuvant Chemotherapy Response [Phase 2, Phase 3]

View source ↗

Summary

SHAPE is a Phase 2/Phase 3 neoadjuvant chemotherapy trial for stage III breast cancer that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Kibo Nam | Conditions: Anatomic Stage III Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma | Phase 2, Phase 3 | Status: RECRUITING